What is Exagen Inc.'s software and technology licenses, net?

Exagen Inc. (XGN) reported software and technology licenses, net of $584K in Q1 2026.

How has Exagen Inc.'s software and technology licenses, net changed year-over-year?

Exagen Inc.'s software and technology licenses, net decreased by 2.0% year-over-year, from $596K to $584K.

What is the long-term trend for Exagen Inc.'s software and technology licenses, net?

Over 5 years (2020 to 2025), Exagen Inc.'s software and technology licenses, net has grown at a 24.8% compound annual growth rate (CAGR), from $250K to $756K.

Exagen Inc. XGN Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Labcorp HoldingsLH

——

Quest DiagnosticsDGX

——

Vor BiopharmaVOR

——

CareDxCDNA

——

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s software and technology licenses, net?: Exagen Inc. (XGN) reported software and technology licenses, net of $584K in Q1 2026.
How has Exagen Inc.'s software and technology licenses, net changed year-over-year?: Exagen Inc.'s software and technology licenses, net decreased by 2.0% year-over-year, from $596K to $584K.
What is the long-term trend for Exagen Inc.'s software and technology licenses, net?: Over 5 years (2020 to 2025), Exagen Inc.'s software and technology licenses, net has grown at a 24.8% compound annual growth rate (CAGR), from $250K to $756K.